News

BarentsKrans advised Benedictus Holding B.V. and T. Kuyvenhoven Holding B.V. on the sale of Liones Holding B.V.

BarentsKrans has advised Benedictus Holding B.V. and T. Kuyvenhoven Holding B.V. on the sale of Liones Holding B.V., a company that provides software for structured content authoring through its Dutch subsidiaries (among which Fonto Group B.V.), to SDL Holdings B.V., a (indirect) subsidiary of the British RWS Holdings. Through this sale, Liones Holding B.V. and
Read more ›

BarentsKrans has advised Axion BioSystems on its acquisition of CytoSMART

Axion BioSystems, a leading life sciences tools company focused on advanced live-cell assay systems, announces the acquisition of the Netherlands-based CytoSMART Technologies—an innovator in kinetic live-cell imaging analysis. The collaboration positions Axion for significant expansion in the fields of stem cell research, immuno-oncology, cell-based therapies, and drug discovery. “Since Axion BioSystems’ inception, our focus has
Read more ›

BarentsKrans advices sell-side in acquisition Eekels Pompen by Boels

BarentsKrans advised sell-side regarding the sale of Eekels Pompen B.V. and Eekels Materieelbeheer B.V. (in short: Eekels Pompen) to Boels-Gosink B.V., a subsidiary within the Boels group. Eekels Pompen has been offering specialised solutions in the area of pump installations for over a hundred years and contributes to national and international (pump) projects with more
Read more ›

BarentsKrans assisted VanderSat Holding on the sale of VanderSat to Planet Labs

BarentsKrans advised VanderSat Holding on the sale of specialized Dutch software developer VanderSat to Planet Labs, an American satellite company based in San Francisco. The transaction closed on 13 December 2021. Through this sale, VanderSat will be able to broaden its network and possibilities to use its science and technology on an even larger scale.
Read more ›

BarentsKrans advises the shareholders of Just-BI on the sale of their shares to EPAM Systems

BarentsKrans has advised the shareholders of Just-BI on the sale of their shares to EPAM Systems Just-BI is involved in end-to-end design and implementation projects in a range of major national and international companies. Just-BI offers a core of senior consultants who support your business every step of the way. Rad Parvn, Just-BI CEO says
Read more ›

BarentsKrans advises Angelini Pharma on the acquisition of the shares in Arvelle Therapeutics

BarentsKrans has advised Angelini Pharma on the acquisition of the shares in Arvelle Therapeutics. Arvelle Therapeutics, a Swiss-based biopharmaceutical company focused on bringing innovative treatments to patients suffering from CNS (Central Nervous System) disorders. “At Angelini Pharma, we are thrilled to sign this promising agreement and are enthusiastic about the commitment and work that our
Read more ›